Interleukin-6 receptor blockade selectively reduces IL-21 production by CD4 T cells and IgG4 autoantibodies in rheumatoid arthritis. - Wikidata - wikimedia - TriplyDB

Interleukin-6 receptor blockade selectively reduces IL-21 production by CD4 T cells and IgG4 autoantibodies in rheumatoid arthritis.

Interleukin-6 receptor blockade selectively reduces IL-21 production by CD4 T cells and IgG4 autoantibodies in rheumatoid arthritis.

http://www.wikidata.org/entity/Q36682022

about

Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date IL-6 in inflammation, immunity, and disease Elevated serum IgG4 defines specific clinical phenotype of rheumatoid arthritis Low baseline interleukin-17A levels are associated with better treatment response at 12 weeks to tocilizumab therapy in rheumatoid arthritis patients.CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis.Rheumatoid arthritis with deficiency pattern in traditional chinese medicine shows correlation with cold and hot patterns in gene expression profiles Interleukin 6 and rheumatoid arthritis Intravenous tocilizumab: a review of its use in adults with rheumatoid arthritis.B-cell hyperactivity in primary Sjögren's syndrome.Interleukin-21: a double-edged sword with therapeutic potential.Specific therapy to regulate inflammation in rheumatoid arthritis: molecular aspects.IL-21 as a therapeutic target in inflammatory disorders.Multifaceted role of IL-21 in rheumatoid arthritis: Current understanding and future perspectives.A review on interleukins: The key manipulators in rheumatoid arthritis.Susceptibility to hepatocellular carcinoma in the Chinese population--associations with interleukin-6 receptor polymorphism.B-cell phenotype and IgD-CD27- memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis.Interleukin-6 receptor alpha blockade improves skin lesions in a murine model of systemic lupus erythematosus.Can IL-6 blockade rectify imbalance between Tregs and Th17 cells?A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer.A New Perspective: Mitochondrial Stat3 as a Regulator for Lymphocyte Function.Baicalin and Baicalein Inhibit Src Tyrosine Kinase and Production of IL-6

P2860

Q26824970-9E722F36-4171-4AD3-8927-7CF3D5CA4961 Q28076558-FE233818-991D-4345-945D-F014B7B73F1F Q34248105-C9833C8A-5B5D-4026-8063-0D3016F64C09 Q34754719-719ADABA-E28B-4831-998F-A5B4E1664645 Q35438412-FBA6C6C3-EB1A-47D4-A11E-37DF265DBF65 Q35555943-0EEF07A1-288A-467E-87D4-E9A09A82005F Q37224843-7FBD9B8D-E683-4176-A869-79632D2889A3 Q37553940-8C6C6E2C-6B7A-4525-853C-F3CF3DD0C227 Q38164315-E4D8587D-5F7F-4EBE-AEAF-60BB5B963923 Q38190590-F6B67BAD-AE98-4CEB-847F-906E62DE0C24 Q38206058-C4A18302-205B-4805-925A-C4770C8771DD Q38217595-92D8AF09-ADDD-4278-9673-963C13A2A19D Q38243870-9EB53691-DD31-436E-A312-290492F432A4 Q38638262-CE244203-0203-410A-8670-1B32EC71B64F Q39029629-51520428-DC8D-450C-80A2-A824CE34B9E9 Q39222750-7941FCCA-7533-48D3-B3E5-F7CD276953EF Q41500669-05D22C12-6081-47E1-AF0C-F88F1B7EBA4B Q41908236-D1C85042-50B1-4047-9BB3-508E5EBF42E4 Q44212684-2D229D8F-83B8-42F9-AF1C-B0FA43D22527 Q53405410-37C575B5-6E0B-4A2F-855E-7AFD9B028141 Q55562159-DA6B79B9-0993-47ED-9B7D-3EB1213DE41B Q59125453-F1090144-A34E-4DFB-8A66-98EF8A6C47FC

P2860

Interleukin-6 receptor blockade selectively reduces IL-21 production by CD4 T cells and IgG4 autoantibodies in rheumatoid arthritis.

http://www.wikidata.org/entity/Q36682022

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Interleukin-6 receptor blockad ...... odies in rheumatoid arthritis.

@ast

Interleukin-6 receptor blockad ...... odies in rheumatoid arthritis.

@en

type

label

Interleukin-6 receptor blockad ...... odies in rheumatoid arthritis.

@ast

Interleukin-6 receptor blockad ...... odies in rheumatoid arthritis.

@en

prefLabel

Interleukin-6 receptor blockad ...... odies in rheumatoid arthritis.

@ast

Interleukin-6 receptor blockad ...... odies in rheumatoid arthritis.

@en

P1433

Q36682022-4DA64426-7E9E-4CC5-A219-DCC459057C90

P1476

Q36682022-8EB31842-6DAF-46AC-8C6E-D56027A5C670

P2093

Q36682022-1EF58671-A26B-4CCD-8C54-AEA578C14DBD

Q36682022-290D89F2-91C1-43F8-B25D-D6AEF4AD0CC1

Q36682022-38EA14F2-DE9B-4C36-AE40-F260F33CB590

Q36682022-A81CD27F-A4CE-4696-862D-0E7C7E53E05E

Q36682022-D7807D86-B1D6-4651-A789-6D036C546ACE

P2860

Q36682022-07594482-A92A-4B2C-9A5C-F2102A01B3B0

Q36682022-0A85CB85-9E23-4033-86E2-554076DF5F7F

Q36682022-14041B0F-978D-4F7F-A8D0-43A79C932983

Q36682022-14AB805A-AEC4-4763-8EC0-FDF40490C074

Q36682022-19E4DB7B-BD35-4281-870A-3793AD890060

Q36682022-1A5B2E48-66A8-4F4A-AC4E-F4E391CE0057

Q36682022-1D9A3163-FBA0-411D-B599-F4A0830A6982

Q36682022-2C6C521D-A1A5-408B-983F-8CA28794B0A9

Q36682022-31BD9EE4-EFF9-4B38-B7B8-F51F0D58282E

Q36682022-3D33152F-6F33-48C7-8B83-9C78E33C2AFE

P304

Q36682022-7A46E759-06B1-42F9-8621-4025F8B95507

P31

Q36682022-330ADD31-665C-436C-8EE2-CF82207D84AB

P356

Q36682022-CC847228-A2B5-4CF1-BF0E-84591598F571

P407

Q36682022-83ECD57E-AE17-4B33-9C69-D726524AA530

P433

Q36682022-5D1A1833-E5F2-46FF-ACD0-44E6C5B1B6C5

P478

Q36682022-F2231E9A-C396-4C7A-A475-9396DA01CFE6

P50

Q36682022-5CA8B444-A599-4EF5-9D9E-5987381B3CCE

P577

Q36682022-AB0E3933-9E9F-44F1-84D3-BC0F0158EDA5

P5875

Q36682022-85E1B138-9569-44D7-AB99-08B12657405A

P698

Q36682022-95ABA9D2-3949-4542-8E8C-61345D145EE0

P921

Q36682022-4120D6CB-EC92-4104-B98D-C97AC18440CA

P932

Q36682022-4E0E7ED7-A252-4EA4-819F-73480EDB63FB

P356

P1433

International Journal of Biological Sciences

P1476

Interleukin-6 receptor blockad ...... odies in rheumatoid arthritis.

@en

P2093

Augusta Wilson

http://www.w3.org/2001/XMLSchema#string

Gustavo Carbone

http://www.w3.org/2001/XMLSchema#string

Janice Bunn

http://www.w3.org/2001/XMLSchema#string

Mercedes Rincon

http://www.w3.org/2001/XMLSchema#string

Sheldon M Cooper

http://www.w3.org/2001/XMLSchema#string

P2860

Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

A critical role for IL-21 in regulating immunoglobulin production

Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration

IgG4-related disease

Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic dr

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

Identification of natural bispecific antibodies against cyclic citrullinated peptide and immunoglobulin G in rheumatoid arthritis

IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation.

P304

279-288

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/IJBS.5996

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236048086

http://www.w3.org/2001/XMLSchema#string

P698

23493630

http://www.w3.org/2001/XMLSchema#string

P921

P932

3596713

http://www.w3.org/2001/XMLSchema#string